Aug 2026· American Journal of Physiology. Heart and Circulatory Physiology· 0 citations
Medicine
TL;DR
The identification of a high-risk SSI, based on 24-hour ABPM, is validated as a generalizable implementable approach for the clinical diagnosis of the SSBP, with a potential greater clinical diagnostic value in hypertensive versus normotensive individuals.
Abstract
The salt sensitivity of blood pressure (SSBP) is rarely assessed and represents a critical barrier in precision hypertension treatment. The current approaches to assess salt sensitivity are labor and resource intensive limiting their clinical implementation. The salt sensitivity index (SSI), derived from 24-hour ambulatory blood pressure monitoring (ABPM) data, has been proposed as a clinical diagnostic approach to classify individuals at low-, intermediate-, or high-risk for the SSBP. This study utilized the Dietary Approaches to Stop Hypertension (DASH)-Sodium Trial control diet arm dataset (N=170), in which the SSBP was assessed by the gold standard dietary approach, to address the hypothesis that identification of a high-risk SSI can predict the individual SSBP. In the high-risk SSI category 72% of DASH-Sodium Trial participants exhibited a salt-sensitive phenotype. For all participants with a high-risk SSI (male and female and normotensive and hypertensive) sensitivity (ability to correctly identify individuals with the SSBP) was 85%, specificity (ability to correctly identify individuals without the SSBP) was 41%, positive predictive value (probability that a person who tests positive has the SSBP) was 72%, negative predictive value was 60% (probability that a person who tests negative does not have the SSBP) and accuracy was 69%. For hypertensive participants only with a high-risk SSI (males and females), sensitivity was 86%, specificity was 44%, the positive predictive value increased to 83%, the negative predictive value was 50% and accuracy increased to 76%. This study validates the identification of a high-risk SSI, based on 24-hour ABPM, as a generalizable implementable approach for the clinical diagnosis of the SSBP, with a potential greater clinical diagnostic value in hypertensive versus normotensive individuals.
The results of the CareBP study show the extended value of 14 days of individual blood pressure monitoring and underline the relevance of this approach for cardiovascular disease prevention.
Sabina Schlottau, S. Läer, Willi Cawello· Frontiers in Cardiovascular...· 0 citations
This represents the first evaluation of a Device Type 3 cuffless blood pressure algorithm (automated, wearable, demographic-calibrated, not at heart level) meeting ESH awake/asleep test criteria, suggesting Alysis-001's potential as a clinically viable alternative for ambulatory blood pressure monitoring in hypertensiv...
K. Hongyo, Atsushi Hirayama, Kosuke Shimizu et al.· Hypertension Research· 0 citations
Nighttime SBP variability (SD) from ABPM independently predicts subclinical TOD and guides organ protection in hypertension and subclinical TOD prediction in hypertension is confirmed.
It is suggested that routinely measured clinical characteristics may help identify populations with greater expected blood pressure response to sodium reduction, and salt sensitivity varied across age, SBP, and body mass index strata.
ABPM improves the diagnostic classification of hypertension and reveals a high prevalence of discordant phenotypes and nocturnal blood pressure abnormalities, and wider use of ABPM may help optimize patient management in this setting.
N. Gaye, J. Mingou, Coumba Kaba et al.· Cardiology and Cardiovascula...· 0 citations
The large number of participants with elevated BP and known hypertension and/or diabetes suggests that improvements are needed in the primary health care setting to support patients in reaching their BP targets.
Stephen D. Coombs, Stephanie W. Young, Ross T. Tsuyuki et al.· Canadian Pharmacists Journal...· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.